Jazz plans early July launch for sleepiness med Sunosi after DEA scheduling

Jazz plans early July launch for sleepiness med Sunosi after DEA scheduling

Source: 
Fierce Pharma
snippet: 

Jazz Pharmaceuticals has had an FDA approval in hand for sleepiness med Sunosi for months, but now it can start planning its official rollout. On Monday, the Drug Enforcement Agency tagged the drug with a Schedule IV designation, setting Jazz up for a launch next month.